Thank you, you are now logged in. x
PBAC knocks back bowel cancer drug

comments

PBAC knocks back bowel cancer drug

TGA-approved multikinase inhibitor will not get PBS listing because of ‘small and of uncertain clinical significance’

Read more

Cancer categories recast in largest-ever genomic study

comments

Cancer categories recast in largest-ever genomic study

US researchers make striking findings for bladder cancers and confirm differences between basal-like and luminal cancers

Read more

Tired doctors at risk of missing adenomas

comments

Tired doctors at risk of missing adenomas

Study of 9,300 patients finds 24% decrease in detection rate when an investigator is on call the night before

Read more

Oncologist warns of endometrial cancer tsunami

comments

Oncologist warns of endometrial cancer tsunami

Increasing number of obese girls is one of the biggest concerns

Read more

Study shows high drop-off in breast cancer treatment

comments

Study shows high drop-off in breast cancer treatment

More than 50% of Australian women with hormone-positive breast cancer abandon their endocrine therapy before five years, according to a study of prescription, Medicare and hospital data.

Read more

Latest News

view more
to get Oncology Update delivered to your inbox

Browse our newsletter archive

Advertisement

Oncology Update on Twitter

­